N-Nitroso Elagolix Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Elagolix is used to manage pain due to endometriosis (a condition in which the type of tissue that lines the uterus [womb] grows in other areas of the body and causes infertility, pain before and during menstrual periods, pain during and after sexual activity, and heavy or irregular bleeding).N-Nitroso Elagolix Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Elagolix Impurity 2 CAS NO:NA chemically represented as (S)-4-((2-(5-(2-Fluoro-3-methoxyphenyl)-4-((5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)methyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)(nitroso)amino)butanoic acid.Synchemia is the leading manufacturing and exporter of N-Nitroso Elagolix Impurity 2. We supply N-Nitroso Elagolix Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143905 |
| CAS No | NA |
| Mol.F. | C16H21ClN6O4 |
| Mol.Wt. | 396.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143906 |
| CAS No | NA |
| Mol.F. | C19H26N6O6S |
| Mol.Wt. | 466.51 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143907 |
| CAS No | NA |
| Mol.F. | C28H24N8O4 |
| Mol.Wt. | 507.55 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143908 |
| CAS No | NA |
| Mol.F. | C16H7N3O9S2 : 2Na |
| Mol.Wt. | 449.4 : 2(23.0) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143909 |
| CAS No | NA |
| Mol.F. | C16H7N3O9S2 : 2(Na) |
| Mol.Wt. | 449.4 : 2(23.0)g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143910 |
| CAS No | NA |
| Mol.F. | C16H6N4O10S2 : 2(Na) |
| Mol.Wt. | 478.4 : 2(23.0) g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143911 |
| CAS No | NA |
| Mol.F. | C11H10N6O2 |
| Mol.Wt. | 258.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143912 |
| CAS No | NA |
| Mol.F. | C11H11N5O |
| Mol.Wt. | 229.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143913 |
| CAS No | NA |
| Mol.F. | C11H9N5O2 |
| Mol.Wt. | 243.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143914 |
| CAS No | NA |
| Mol.F. | C15H15Cl2N7O9S4 |
| Mol.Wt. | 636.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143915 |
| CAS No | 664985-71-1 |
| Mol.F. | C3H6N2O2 |
| Mol.Wt. | 102.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143916 |
| CAS No | 60391-92-6 |
| Mol.F. | C3H5N3O4 |
| Mol.Wt. | 147.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143917 |
| CAS No | NA |
| Mol.F. | C10H22N2O3 |
| Mol.Wt. | 218.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143918 |
| CAS No | NA |
| Mol.F. | C15H14N2O3 |
| Mol.Wt. | 270.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143919 |
| CAS No | NA |
| Mol.F. | C14H20N2O2 |
| Mol.Wt. | 248.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143920 |
| CAS No | 943-41-9 |
| Mol.F. | C7H7N3O3 |
| Mol.Wt. | 182.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |